-- エーザイ（東証：4523）は、アルツハイマー病治療薬「レケンビ」の2023年3月期の世界売上高が、速報値で880億円に達したと発表した。
米国での売上高は446億円、次いで日本が244億円、中国が124億円となった。
Related Articles
Asia
Central China Securities' Profit Surges 64% in Q1
Central China Securities (HKG:1375, SHA:601375) posted net profit attributable to shareholders of 168.7 million yuan for the first quarter, up 64% from 103 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Shares of the brokerage were down nearly 1% in Thursday's midday trade.Earnings per share came in at 0.0363 yuan from 0.0222 yuan a year earlier.Operating income increased 34% to 537.6 million yuan from 401 million yuan in the prior-year period.
$HKG:1375$SHA:601375
Asia
RailTel Corporation Bags Order Worth INR138 Million for Supply of Computers
RailTel Corporation of India (NSE:RAILTEL, BOM:543265) has secured an order worth 138.4 million Indian rupees from the Directorate of Education, India, according to a Thursday filing to the Indian stock exchanges.The contract is for the setup of computer labs and the supply of laptops in government schools in Delhi, India, under the Directorate of Education, Government of NCT of Delhi.The project entails the supply, installation, commissioning, and comprehensive maintenance services for a period of five years for the equipment. It is scheduled for completion by April 29, 2031.The company's shares were down nearly 2% in recent trade in a weak broad market.
$BOM:543265$NSE:RAILTEL
Asia
China Longyuan Power Completes 1.8 Billion Yuan Debt Offering
China Longyuan Power (HKG:0916, SHE:001289) said it completed a 1.8 billion yuan issue of ultra short-term debentures, according to a Hong Kong bourse filing Wednesday.The power company's Hong Kong shares gained 5% in late morning trade Thursday.The debt has a term of 148 days and a coupon rate of 1.35%.Proceeds from the sale will be used to repay the company's previously issued debt.
$HKG:0916$SHE:001289